(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ANKET

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ANKET

ST13

US500000097085429

Class

1, 5, 42

Filing

97085429

Registration

6952905

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

01/17/2023

Trademark type

Word

Nice classes

1, 5, 42

Filing date

10/21/2021

Registration date

01/17/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/17/2023

Last transaction

01/17/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

03

Owner location

MARSEILLE, FR

Examiner

AURAND, MEGAN LEE

Law office

O10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

I. P. (pessoa física)

Representatives

Corey K. Cho SALIWANCHIK LLOYD & EISENSCHENK, P.A.

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical or biotechnological products for industry and sciencepolypeptides and proteins; biological preparationsin particular antibodies in the nature of monoclonal antibodiesbispecific antibodies or multifunctional antibodiesantibody derivatives in the nature of antibody fragmentssingle-chain variable fragmentsdi-scFvlight and heavy chains of antibodiesbinding proteins and peptides having a binding affinity to immune cells in the nature of T-cell engagers or NK-cell engagersfor laboratory and experimental purposesin particular for conducting experimental tests other than for medical use; Biochemicalspolypeptides for in vitro research use

Class 5

Pharmaceuticalsmedicalbiological or biochemical preparationssubstances for the treatment of diseasesas well as preparations for medical treatmentsin particularantibodies and derivatives being monoclonal antibodiesbispecific antibodiesmultispecific antibodiesantibody fragmentssingle-chain variable fragmentsdi-scFv or light and heavy chains of antibodies for medical purposesbifunctional or multifunctional proteins being T-cell engagers or NK cell engagers for medical purposes with binding affinity to immune cellsin particular NK cellsother reagents for the diagnosispreventionmonitoring and treatment of diseasesin particular cancersinfectious diseasesinflammatory diseasesother immune pathologies

Class 42

Scientific and technological servicesresearch and development in scientific and medical mattersin particular in the field of immunotherapy; scientific and technological servicesscientific research and development related to diagnostic products; pharmaceutical and biotechnological scientific laboratory services; laboratory researchanalysisevaluationdevelopment and clinical trial of therapeutic compositions and treatments in the field of oncology; all of the above services concerning the use of antibodiesantibody derivativesproteinsother agents for activating or modulating natural and adaptive immunity

Publications

History of USPTO decisions and trademark events.

15 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/17/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/17/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/01/2022

PUBO

PUBLISHED FOR OPPOSITION

11/01/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/12/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/27/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/24/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/23/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/23/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/08/2022

GNRT

NON-FINAL ACTION E-MAILED

08/08/2022

CNRT

NON-FINAL ACTION WRITTEN

08/08/2022

DOCK

ASSIGNED TO EXAMINER

07/28/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/07/2021

NWAP

NEW APPLICATION ENTERED

10/25/2021

Continuous trademark protection

Get notified about every new filing that threatens ANKET or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.